Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001579412 | SCV001814828 | likely benign | not provided | 2021-06-22 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002276813 | SCV002566309 | likely benign | Ehlers-Danlos syndrome | 2021-09-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002368605 | SCV002664167 | likely benign | Cardiovascular phenotype | 2022-04-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001579412 | SCV001807140 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001579412 | SCV001927871 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579412 | SCV001975082 | likely benign | not provided | no assertion criteria provided | clinical testing |